Table 1. Results of HCV testing of... | American Society of Hematology

Table 1.

Results of HCV testing of surviving patients who received blood products

Date of Cancer Diagnosis	Number of Transfused Survivors	Number Tested for HCV	HCV-Infected^* (% tested)
Before 1986^†	1502	550	59 (10.7)
1986 to 5/3/90^‡	525	436	17 (3.9)
5/4/90 to 3/12/92^1-153	284	189	1 (0.5)
Totals, 1961 to 3/12/92^1-155	2311	1175	77 (6.6)

Date of Cancer Diagnosis	Number of Transfused Survivors	Number Tested for HCV	HCV-Infected^* (% tested)
Before 1986^†	1502	550	59 (10.7)
1986 to 5/3/90^‡	525	436	17 (3.9)
5/4/90 to 3/12/92^1-153	284	189	1 (0.5)
Totals, 1961 to 3/12/92^1-155	2311	1175	77 (6.6)

Positive EIA-2 and RIBA-2, or positive HCV RNA by PCR.

Before HCV screening of blood products.

Screening of blood products with serum ALT levels.

Screening of blood products with EIA-1.

Four additional patients, diagnosed and transfused after 3/12/92, are also infected with HCV.